XML 57 R45.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Business Acquisition Bus acquisition - Table of acquired Intangibles (Details) (USD $) | 12 Months Ended
--- | ---
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011
Acquired Finite-Lived Intangible Assets [Line Items] |  |  |
Business Combination, Acquisition Related Costs |  | $ 3,200,000 |
Revenues | 380,585,000 | 314,027,000 | 245,535,000
Net Income (Loss) Available to Common Stockholders, Basic | 23,979,000 | 16,178,000 | 10,389,000
Trade Names [Member] | Minimum [Member] |  |  |
Acquired Finite-Lived Intangible Assets [Line Items] |  |  |
Finite-Lived Intangible Asset, Useful Life | 3 years |  |
Trade Names [Member] | Maximum [Member] |  |  |
Acquired Finite-Lived Intangible Assets [Line Items] |  |  |
Finite-Lived Intangible Asset, Useful Life | 12 years |  |
Customer Relationships [Member] | Minimum [Member] |  |  |
Acquired Finite-Lived Intangible Assets [Line Items] |  |  |
Finite-Lived Intangible Asset, Useful Life | 5 years |  |
Customer Relationships [Member] | Maximum [Member] |  |  |
Acquired Finite-Lived Intangible Assets [Line Items] |  |  |
Finite-Lived Intangible Asset, Useful Life | 30 years |  |
Acquired Technology [Member] | Minimum [Member] |  |  |
Acquired Finite-Lived Intangible Assets [Line Items] |  |  |
Finite-Lived Intangible Asset, Useful Life | 3 years |  |
Acquired Technology [Member] | Maximum [Member] |  |  |
Acquired Finite-Lived Intangible Assets [Line Items] |  |  |
Finite-Lived Intangible Asset, Useful Life | 20 years |  |
MTS-Medication Technologies [Member] |  |  |
Acquired Finite-Lived Intangible Assets [Line Items] |  |  |
Acquired Finite-lived Intangible Asset, Amount |  | 83,900,000 |
Expected amortization of acquired intangibles first year |  | 3,604,000 |
Weighted average life of intangibles | 25 years 1 month 21 days |  |
Revenues |  | 47,200,000 |
MTS-Medication Technologies [Member] | Minimum [Member] |  |  |
Acquired Finite-Lived Intangible Assets [Line Items] |  |  |
Weighted average life of intangibles | 12 years |  |
MTS-Medication Technologies [Member] | Maximum [Member] |  |  |
Acquired Finite-Lived Intangible Assets [Line Items] |  |  |
Weighted average life of intangibles | 30 years |  |
MTS-Medication Technologies [Member] | Trade Names [Member] |  |  |
Acquired Finite-Lived Intangible Assets [Line Items] |  |  |
Acquired Finite-lived Intangible Asset, Amount |  | 6,800,000 |
Finite-Lived Intangible Asset, Useful Life | 12 years |  |
Expected amortization of acquired intangibles first year |  | 567,000 |
MTS-Medication Technologies [Member] | Customer Relationships [Member] |  |  |
Acquired Finite-Lived Intangible Assets [Line Items] |  |  |
Acquired Finite-lived Intangible Asset, Amount |  | 50,500,000 |
Expected amortization of acquired intangibles first year |  | 1,707,000 |
MTS-Medication Technologies [Member] | Customer Relationships [Member] | Minimum [Member] |  |  |
Acquired Finite-Lived Intangible Assets [Line Items] |  |  |
Finite-Lived Intangible Asset, Useful Life | 28 years |  |
MTS-Medication Technologies [Member] | Customer Relationships [Member] | Maximum [Member] |  |  |
Acquired Finite-Lived Intangible Assets [Line Items] |  |  |
Finite-Lived Intangible Asset, Useful Life | 30 years |  |
MTS-Medication Technologies [Member] | Acquired Technology [Member] |  |  |
Acquired Finite-Lived Intangible Assets [Line Items] |  |  |
Acquired Finite-lived Intangible Asset, Amount |  | 26,600,000 |
Finite-Lived Intangible Asset, Useful Life | 20 years |  |
Expected amortization of acquired intangibles first year |  | 1,330,000 |
Non-acute care solutions [Member] |  |  |
Acquired Finite-Lived Intangible Assets [Line Items] |  |  |
Revenues | 95,919,000 | 53,867,000 |
Non-acute care solutions [Member] | MTS-Medication Technologies [Member] |  |  |
Acquired Finite-Lived Intangible Assets [Line Items] |  |  |
Net Income (Loss) Available to Common Stockholders, Basic |  | $ 2,900,000 |

X
- Definition Expected amortization of acquired intangibles first year = for twelve months following acquisition date, the expected amortization expense from the amortizable intangibles acquired. + References No definition available. + Details
Name: | omcl_ExpectedAmortizationOfAcquiredIntangiblesFirstYear
Namespace Prefix: | omcl_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (a)(3) -URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16265-109275 + Details
Name: | us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 25 -Paragraph 23 -URI http://asc.fasb.org/extlink&oid=21917927&loc=d3e1043-128460 + Details
Name: | us-gaap_BusinessCombinationAcquisitionRelatedCosts
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, resulting from a business combination. + References No definition available. + Details
Name: | us-gaap_FinitelivedIntangibleAssetsAcquired1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | us-gaap_FiniteLivedIntangibleAssetUsefulLife
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 11 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1377-109256 + Details
Name: | us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 + Details
Name: | us-gaap_Revenues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration